nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—breast cancer	0.309	1	CbGaD
Fluocinolone Acetonide—PLA2G4A—Epirubicin—breast cancer	0.113	0.506	CbGbCtD
Fluocinolone Acetonide—NR3C1—Fluoxymesterone—breast cancer	0.11	0.493	CbGbCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Exemestane—breast cancer	0.0298	0.0946	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Exemestane—breast cancer	0.0278	0.0884	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Exemestane—breast cancer	0.0273	0.0865	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Fluoxymesterone—breast cancer	0.0228	0.0724	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0222	0.0706	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Fluoxymesterone—breast cancer	0.0222	0.0706	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Fluoxymesterone—breast cancer	0.0211	0.0671	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Fluoxymesterone—breast cancer	0.0206	0.0655	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Fluoxymesterone—breast cancer	0.0206	0.0655	CrCrCtD
Fluocinolone Acetonide—Mometasone—Fluoxymesterone—breast cancer	0.0206	0.0655	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0206	0.0655	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Fluoxymesterone—breast cancer	0.0202	0.064	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Fluoxymesterone—breast cancer	0.0202	0.064	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Fluoxymesterone—breast cancer	0.0189	0.06	CrCrCtD
Fluocinolone Acetonide—PLA2G4A—nipple—breast cancer	0.00127	0.0889	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Fulvestrant—breast cancer	0.00106	0.531	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—endometrium—breast cancer	0.000764	0.0537	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—pituitary gland—breast cancer	0.000691	0.0486	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adipose tissue—breast cancer	0.000689	0.0484	CbGeAlD
Fluocinolone Acetonide—SERPINA6—pituitary gland—breast cancer	0.000689	0.0484	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—female reproductive system—breast cancer	0.000633	0.0445	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Raltitrexed—Methotrexate—breast cancer	0.000632	0.318	CbGdCrCtD
Fluocinolone Acetonide—SERPINA6—female reproductive system—breast cancer	0.00063	0.0443	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adrenal gland—breast cancer	0.000618	0.0434	CbGeAlD
Fluocinolone Acetonide—SERPINA6—adrenal gland—breast cancer	0.000615	0.0432	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bone marrow—breast cancer	0.000598	0.042	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—breast cancer	0.000595	0.0418	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—female gonad—breast cancer	0.000576	0.0405	CbGeAlD
Fluocinolone Acetonide—NR3C1—nipple—breast cancer	0.000552	0.0388	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—endocrine gland—breast cancer	0.000536	0.0376	CbGeAlD
Fluocinolone Acetonide—SERPINA6—endocrine gland—breast cancer	0.000533	0.0375	CbGeAlD
Fluocinolone Acetonide—NR3C1—embryo—breast cancer	0.000455	0.032	CbGeAlD
Fluocinolone Acetonide—NR3C1—epithelium—breast cancer	0.000372	0.0261	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—breast cancer	0.00037	0.026	CbGeAlD
Fluocinolone Acetonide—NR3C1—skin of body—breast cancer	0.000353	0.0248	CbGeAlD
Fluocinolone Acetonide—NR3C1—endometrium—breast cancer	0.000333	0.0234	CbGeAlD
Fluocinolone Acetonide—NR3C1—uterus—breast cancer	0.000307	0.0216	CbGeAlD
Fluocinolone Acetonide—NR3C1—pituitary gland—breast cancer	0.000302	0.0212	CbGeAlD
Fluocinolone Acetonide—NR3C1—adipose tissue—breast cancer	0.0003	0.0211	CbGeAlD
Fluocinolone Acetonide—NR3C1—female reproductive system—breast cancer	0.000276	0.0194	CbGeAlD
Fluocinolone Acetonide—NR3C1—adrenal gland—breast cancer	0.000269	0.0189	CbGeAlD
Fluocinolone Acetonide—NR3C1—bone marrow—breast cancer	0.000261	0.0183	CbGeAlD
Fluocinolone Acetonide—NR3C1—female gonad—breast cancer	0.000251	0.0177	CbGeAlD
Fluocinolone Acetonide—NR3C1—endocrine gland—breast cancer	0.000234	0.0164	CbGeAlD
Fluocinolone Acetonide—Fluticasone Propionate—PLA2G4A—breast cancer	0.000169	0.0876	CrCbGaD
Fluocinolone Acetonide—NR3C1—lymph node—breast cancer	0.000161	0.0114	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Fluoxymesterone—breast cancer	0.000151	0.0758	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Fluoxymesterone—breast cancer	0.000151	0.0758	CbGdCrCtD
Fluocinolone Acetonide—Fludrocortisone—AR—breast cancer	0.000131	0.0676	CrCbGaD
Fluocinolone Acetonide—Fluticasone Propionate—PGR—breast cancer	0.000112	0.0579	CrCbGaD
Fluocinolone Acetonide—Betamethasone—PGR—breast cancer	0.000103	0.0531	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—BCHE—breast cancer	8.57e-05	0.0444	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP17A1—breast cancer	8.04e-05	0.0416	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—breast cancer	8.04e-05	0.0416	CrCbGaD
Fluocinolone Acetonide—Betamethasone—CYP19A1—breast cancer	7.04e-05	0.0364	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NOS2—breast cancer	6.56e-05	0.0339	CrCbGaD
Fluocinolone Acetonide—Budesonide—CYP3A4—breast cancer	6.12e-05	0.0317	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—CYP3A4—breast cancer	6e-05	0.0311	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—PGR—breast cancer	5.97e-05	0.0309	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP1B1—breast cancer	5.58e-05	0.0289	CrCbGaD
Fluocinolone Acetonide—Alclometasone—CYP3A4—breast cancer	5.27e-05	0.0273	CrCbGaD
Fluocinolone Acetonide—Flunisolide—CYP3A4—breast cancer	5.14e-05	0.0266	CrCbGaD
Fluocinolone Acetonide—Paramethasone—CYP3A4—breast cancer	5.07e-05	0.0262	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—breast cancer	5e-05	0.0259	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—CYP3A4—breast cancer	4.95e-05	0.0256	CrCbGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Gemcitabine—breast cancer	4.84e-05	0.000576	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Melphalan—breast cancer	4.82e-05	0.000573	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Capecitabine—breast cancer	4.8e-05	0.000572	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—breast cancer	4.79e-05	0.00057	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—breast cancer	4.79e-05	0.00057	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—breast cancer	4.79e-05	0.00057	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—CYP3A4—breast cancer	4.78e-05	0.0248	CrCbGaD
Fluocinolone Acetonide—Rash—Melphalan—breast cancer	4.78e-05	0.000568	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Melphalan—breast cancer	4.77e-05	0.000568	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Fluorouracil—breast cancer	4.76e-05	0.000567	CcSEcCtD
Fluocinolone Acetonide—Cough—Paclitaxel—breast cancer	4.76e-05	0.000566	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinblastine—breast cancer	4.73e-05	0.000563	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Irinotecan—breast cancer	4.71e-05	0.000561	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Goserelin—breast cancer	4.7e-05	0.000559	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—breast cancer	4.69e-05	0.000558	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vinorelbine—breast cancer	4.68e-05	0.000557	CcSEcCtD
Fluocinolone Acetonide—Pain—Mitoxantrone—breast cancer	4.67e-05	0.000555	CcSEcCtD
Fluocinolone Acetonide—Pain—Irinotecan—breast cancer	4.67e-05	0.000555	CcSEcCtD
Fluocinolone Acetonide—Rash—Goserelin—breast cancer	4.66e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Thiotepa—breast cancer	4.66e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Goserelin—breast cancer	4.65e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—breast cancer	4.65e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Paclitaxel—breast cancer	4.64e-05	0.000553	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Capecitabine—breast cancer	4.63e-05	0.000551	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Epirubicin—breast cancer	4.63e-05	0.000551	CcSEcCtD
Fluocinolone Acetonide—Headache—Goserelin—breast cancer	4.63e-05	0.000551	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—breast cancer	4.62e-05	0.00055	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—breast cancer	4.62e-05	0.00055	CcSEcCtD
Fluocinolone Acetonide—Nausea—Tamoxifen—breast cancer	4.59e-05	0.000547	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Gemcitabine—breast cancer	4.59e-05	0.000546	CcSEcCtD
Fluocinolone Acetonide—Pain—Gemcitabine—breast cancer	4.55e-05	0.000541	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Capecitabine—breast cancer	4.54e-05	0.000541	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vinorelbine—breast cancer	4.53e-05	0.000539	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—breast cancer	4.53e-05	0.000539	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Fluorouracil—breast cancer	4.51e-05	0.000537	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Capecitabine—breast cancer	4.5e-05	0.000536	CcSEcCtD
Fluocinolone Acetonide—Nausea—Melphalan—breast cancer	4.5e-05	0.000535	CcSEcCtD
Fluocinolone Acetonide—Erythema—Capecitabine—breast cancer	4.48e-05	0.000533	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Capecitabine—breast cancer	4.48e-05	0.000533	CcSEcCtD
Fluocinolone Acetonide—Influenza—Epirubicin—breast cancer	4.47e-05	0.000533	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—breast cancer	4.47e-05	0.000532	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Thiotepa—breast cancer	4.47e-05	0.000532	CcSEcCtD
Fluocinolone Acetonide—Pain—Fluorouracil—breast cancer	4.47e-05	0.000532	CcSEcCtD
Fluocinolone Acetonide—Oedema—Paclitaxel—breast cancer	4.45e-05	0.00053	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Methotrexate—breast cancer	4.44e-05	0.000529	CcSEcCtD
Fluocinolone Acetonide—Infection—Paclitaxel—breast cancer	4.42e-05	0.000526	CcSEcCtD
Fluocinolone Acetonide—Nausea—Goserelin—breast cancer	4.39e-05	0.000522	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Capecitabine—breast cancer	4.38e-05	0.000522	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vinorelbine—breast cancer	4.38e-05	0.000521	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Paclitaxel—breast cancer	4.36e-05	0.000519	CcSEcCtD
Fluocinolone Acetonide—Back pain—Capecitabine—breast cancer	4.33e-05	0.000515	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Thiotepa—breast cancer	4.32e-05	0.000515	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Mitoxantrone—breast cancer	4.31e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Irinotecan—breast cancer	4.31e-05	0.000513	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—breast cancer	4.28e-05	0.00051	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Methotrexate—breast cancer	4.26e-05	0.000507	CcSEcCtD
Fluocinolone Acetonide—Infestation—Methotrexate—breast cancer	4.26e-05	0.000507	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Capecitabine—breast cancer	4.22e-05	0.000502	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vinorelbine—breast cancer	4.21e-05	0.000501	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Gemcitabine—breast cancer	4.2e-05	0.0005	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Thiotepa—breast cancer	4.18e-05	0.000497	CcSEcCtD
Fluocinolone Acetonide—Rash—Vinorelbine—breast cancer	4.17e-05	0.000497	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vinorelbine—breast cancer	4.17e-05	0.000496	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Epirubicin—breast cancer	4.16e-05	0.000495	CcSEcCtD
Fluocinolone Acetonide—Headache—Vinorelbine—breast cancer	4.15e-05	0.000493	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—breast cancer	4.14e-05	0.000493	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Fluorouracil—breast cancer	4.13e-05	0.000492	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP19A1—breast cancer	4.09e-05	0.0212	CrCbGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.05e-05	0.000483	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—CYP3A4—breast cancer	4.03e-05	0.0209	CrCbGaD
Fluocinolone Acetonide—Cough—Docetaxel—breast cancer	4.03e-05	0.00048	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Capecitabine—breast cancer	4.02e-05	0.000479	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Mitoxantrone—breast cancer	4.02e-05	0.000479	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Irinotecan—breast cancer	4.02e-05	0.000479	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Thiotepa—breast cancer	4.02e-05	0.000478	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—breast cancer	3.99e-05	0.000475	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—breast cancer	3.99e-05	0.000475	CcSEcCtD
Fluocinolone Acetonide—Rash—Thiotepa—breast cancer	3.98e-05	0.000474	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—breast cancer	3.98e-05	0.0206	CrCbGaD
Fluocinolone Acetonide—Dermatitis—Thiotepa—breast cancer	3.98e-05	0.000474	CcSEcCtD
Fluocinolone Acetonide—Headache—Thiotepa—breast cancer	3.96e-05	0.000471	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—breast cancer	3.95e-05	0.0204	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Docetaxel—breast cancer	3.94e-05	0.000468	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinorelbine—breast cancer	3.93e-05	0.000468	CcSEcCtD
Fluocinolone Acetonide—Cough—Capecitabine—breast cancer	3.91e-05	0.000465	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Fluorouracil—breast cancer	3.85e-05	0.000458	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—breast cancer	3.85e-05	0.000458	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCG2—breast cancer	3.84e-05	0.0199	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Paclitaxel—breast cancer	3.84e-05	0.000457	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Capecitabine—breast cancer	3.81e-05	0.000453	CcSEcCtD
Fluocinolone Acetonide—Pain—Paclitaxel—breast cancer	3.81e-05	0.000453	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—breast cancer	3.77e-05	0.000449	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Gemcitabine—breast cancer	3.76e-05	0.000448	CcSEcCtD
Fluocinolone Acetonide—Nausea—Thiotepa—breast cancer	3.75e-05	0.000447	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—breast cancer	3.75e-05	0.000446	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—breast cancer	3.74e-05	0.000445	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Irinotecan—breast cancer	3.73e-05	0.000444	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Mitoxantrone—breast cancer	3.73e-05	0.000444	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—breast cancer	3.7e-05	0.00044	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fluorouracil—breast cancer	3.7e-05	0.00044	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—breast cancer	3.69e-05	0.000439	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—breast cancer	3.69e-05	0.000439	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Methotrexate—breast cancer	3.69e-05	0.000439	CcSEcCtD
Fluocinolone Acetonide—Oedema—Capecitabine—breast cancer	3.65e-05	0.000435	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Gemcitabine—breast cancer	3.64e-05	0.000433	CcSEcCtD
Fluocinolone Acetonide—Infection—Capecitabine—breast cancer	3.63e-05	0.000432	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Irinotecan—breast cancer	3.61e-05	0.000429	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—CYP3A4—breast cancer	3.61e-05	0.0187	CrCbGaD
Fluocinolone Acetonide—Rhinitis—Epirubicin—breast cancer	3.59e-05	0.000427	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Capecitabine—breast cancer	3.58e-05	0.000426	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Methotrexate—breast cancer	3.58e-05	0.000426	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Fluorouracil—breast cancer	3.58e-05	0.000426	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—breast cancer	3.52e-05	0.000419	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Paclitaxel—breast cancer	3.52e-05	0.000419	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Mitoxantrone—breast cancer	3.47e-05	0.000413	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Irinotecan—breast cancer	3.47e-05	0.000413	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—breast cancer	3.46e-05	0.000412	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Fluorouracil—breast cancer	3.46e-05	0.000411	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—breast cancer	3.45e-05	0.000411	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Methotrexate—breast cancer	3.45e-05	0.00041	CcSEcCtD
Fluocinolone Acetonide—Rash—Irinotecan—breast cancer	3.44e-05	0.00041	CcSEcCtD
Fluocinolone Acetonide—Rash—Mitoxantrone—breast cancer	3.44e-05	0.00041	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Mitoxantrone—breast cancer	3.44e-05	0.000409	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Irinotecan—breast cancer	3.44e-05	0.000409	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.44e-05	0.000409	CcSEcCtD
Fluocinolone Acetonide—Headache—Mitoxantrone—breast cancer	3.42e-05	0.000407	CcSEcCtD
Fluocinolone Acetonide—Headache—Irinotecan—breast cancer	3.42e-05	0.000407	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Methotrexate—breast cancer	3.38e-05	0.000402	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Gemcitabine—breast cancer	3.38e-05	0.000402	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—CYP3A4—breast cancer	3.37e-05	0.0175	CrCbGaD
Fluocinolone Acetonide—Mental disorder—Methotrexate—breast cancer	3.35e-05	0.000399	CcSEcCtD
Fluocinolone Acetonide—Rash—Gemcitabine—breast cancer	3.35e-05	0.000399	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gemcitabine—breast cancer	3.35e-05	0.000399	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—breast cancer	3.35e-05	0.000398	CcSEcCtD
Fluocinolone Acetonide—Erythema—Methotrexate—breast cancer	3.33e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Methotrexate—breast cancer	3.33e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Headache—Gemcitabine—breast cancer	3.33e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.33e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Fluorouracil—breast cancer	3.32e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—breast cancer	3.32e-05	0.000395	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—CYP3A4—breast cancer	3.3e-05	0.0171	CrCbGaD
Fluocinolone Acetonide—Rash—Fluorouracil—breast cancer	3.3e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fluorouracil—breast cancer	3.29e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Paclitaxel—breast cancer	3.28e-05	0.00039	CcSEcCtD
Fluocinolone Acetonide—Headache—Fluorouracil—breast cancer	3.27e-05	0.00039	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Methotrexate—breast cancer	3.26e-05	0.000388	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—breast cancer	3.26e-05	0.000388	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—breast cancer	3.26e-05	0.000388	CcSEcCtD
Fluocinolone Acetonide—Nausea—Mitoxantrone—breast cancer	3.24e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Nausea—Irinotecan—breast cancer	3.24e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—breast cancer	3.24e-05	0.0167	CrCbGaD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—breast cancer	3.23e-05	0.000384	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—breast cancer	3.23e-05	0.000384	CcSEcCtD
Fluocinolone Acetonide—Back pain—Methotrexate—breast cancer	3.22e-05	0.000384	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—breast cancer	3.19e-05	0.00038	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—breast cancer	3.16e-05	0.000377	CcSEcCtD
Fluocinolone Acetonide—Nausea—Gemcitabine—breast cancer	3.16e-05	0.000376	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Capecitabine—breast cancer	3.15e-05	0.000375	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Paclitaxel—breast cancer	3.15e-05	0.000375	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Methotrexate—breast cancer	3.14e-05	0.000374	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Epirubicin—breast cancer	3.14e-05	0.000373	CcSEcCtD
Fluocinolone Acetonide—Pain—Capecitabine—breast cancer	3.12e-05	0.000372	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—breast cancer	3.12e-05	0.000371	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—breast cancer	3.12e-05	0.000371	CcSEcCtD
Fluocinolone Acetonide—Nausea—Fluorouracil—breast cancer	3.1e-05	0.000369	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—breast cancer	3.1e-05	0.000369	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—breast cancer	3.05e-05	0.000363	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Paclitaxel—breast cancer	3.05e-05	0.000362	CcSEcCtD
Fluocinolone Acetonide—Back pain—Epirubicin—breast cancer	3.02e-05	0.000359	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—breast cancer	3.01e-05	0.0156	CrCbGaD
Fluocinolone Acetonide—Vertigo—Methotrexate—breast cancer	2.99e-05	0.000356	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—breast cancer	2.99e-05	0.000355	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—breast cancer	2.98e-05	0.000355	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Paclitaxel—breast cancer	2.94e-05	0.00035	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—breast cancer	2.94e-05	0.00035	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—breast cancer	2.93e-05	0.000349	CcSEcCtD
Fluocinolone Acetonide—Cough—Methotrexate—breast cancer	2.91e-05	0.000346	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—breast cancer	2.9e-05	0.000346	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Capecitabine—breast cancer	2.89e-05	0.000344	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—breast cancer	2.88e-05	0.000343	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—breast cancer	2.88e-05	0.000343	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Methotrexate—breast cancer	2.84e-05	0.000338	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Paclitaxel—breast cancer	2.83e-05	0.000337	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—breast cancer	2.82e-05	0.000336	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—ABCB1—breast cancer	2.81e-05	0.0145	CrCbGaD
Fluocinolone Acetonide—Rash—Paclitaxel—breast cancer	2.81e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Paclitaxel—breast cancer	2.8e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Epirubicin—breast cancer	2.8e-05	0.000333	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—breast cancer	2.79e-05	0.000332	CcSEcCtD
Fluocinolone Acetonide—Headache—Paclitaxel—breast cancer	2.79e-05	0.000332	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—breast cancer	2.78e-05	0.000331	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—ABCB1—breast cancer	2.75e-05	0.0142	CrCbGaD
Fluocinolone Acetonide—Cough—Epirubicin—breast cancer	2.72e-05	0.000324	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—breast cancer	2.72e-05	0.000324	CcSEcCtD
Fluocinolone Acetonide—Infection—Methotrexate—breast cancer	2.7e-05	0.000321	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Capecitabine—breast cancer	2.69e-05	0.00032	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Docetaxel—breast cancer	2.67e-05	0.000318	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Methotrexate—breast cancer	2.67e-05	0.000317	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Epirubicin—breast cancer	2.65e-05	0.000316	CcSEcCtD
Fluocinolone Acetonide—Nausea—Paclitaxel—breast cancer	2.64e-05	0.000315	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—breast cancer	2.59e-05	0.000308	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Capecitabine—breast cancer	2.58e-05	0.000308	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—breast cancer	2.58e-05	0.000307	CcSEcCtD
Fluocinolone Acetonide—Oedema—Epirubicin—breast cancer	2.54e-05	0.000303	CcSEcCtD
Fluocinolone Acetonide—Infection—Epirubicin—breast cancer	2.53e-05	0.000301	CcSEcCtD
Fluocinolone Acetonide—Cough—Doxorubicin—breast cancer	2.52e-05	0.0003	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Capecitabine—breast cancer	2.5e-05	0.000297	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—breast cancer	2.5e-05	0.000297	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Docetaxel—breast cancer	2.49e-05	0.000297	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.48e-05	0.000295	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—breast cancer	2.46e-05	0.000292	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Capecitabine—breast cancer	2.42e-05	0.000287	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—breast cancer	2.4e-05	0.000285	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—breast cancer	2.38e-05	0.000283	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—breast cancer	2.38e-05	0.000283	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—breast cancer	2.36e-05	0.000281	CcSEcCtD
Fluocinolone Acetonide—Oedema—Doxorubicin—breast cancer	2.35e-05	0.00028	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Methotrexate—breast cancer	2.35e-05	0.000279	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—breast cancer	2.34e-05	0.000278	CcSEcCtD
Fluocinolone Acetonide—Pain—Methotrexate—breast cancer	2.33e-05	0.000277	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Capecitabine—breast cancer	2.32e-05	0.000276	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.32e-05	0.000276	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—breast cancer	2.31e-05	0.000275	CcSEcCtD
Fluocinolone Acetonide—Rash—Capecitabine—breast cancer	2.3e-05	0.000274	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Capecitabine—breast cancer	2.3e-05	0.000274	CcSEcCtD
Fluocinolone Acetonide—Headache—Capecitabine—breast cancer	2.29e-05	0.000272	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2D6—breast cancer	2.24e-05	0.0116	CrCbGaD
Fluocinolone Acetonide—Nausea—Docetaxel—breast cancer	2.24e-05	0.000267	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—breast cancer	2.2e-05	0.000261	CcSEcCtD
Fluocinolone Acetonide—Pain—Epirubicin—breast cancer	2.18e-05	0.000259	CcSEcCtD
Fluocinolone Acetonide—Nausea—Capecitabine—breast cancer	2.17e-05	0.000258	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Methotrexate—breast cancer	2.15e-05	0.000256	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.14e-05	0.000255	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—breast cancer	2.03e-05	0.000242	CcSEcCtD
Fluocinolone Acetonide—Pain—Doxorubicin—breast cancer	2.01e-05	0.00024	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—breast cancer	2.01e-05	0.000239	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Methotrexate—breast cancer	2e-05	0.000238	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Methotrexate—breast cancer	1.92e-05	0.000229	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP3A4—breast cancer	1.92e-05	0.00995	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—breast cancer	1.88e-05	0.00974	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—breast cancer	1.87e-05	0.000223	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—breast cancer	1.86e-05	0.000222	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methotrexate—breast cancer	1.86e-05	0.000221	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Epirubicin—breast cancer	1.8e-05	0.000214	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Methotrexate—breast cancer	1.8e-05	0.000214	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—breast cancer	1.74e-05	0.000207	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—breast cancer	1.73e-05	0.000206	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Methotrexate—breast cancer	1.73e-05	0.000206	CcSEcCtD
Fluocinolone Acetonide—Rash—Methotrexate—breast cancer	1.71e-05	0.000204	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Methotrexate—breast cancer	1.71e-05	0.000204	CcSEcCtD
Fluocinolone Acetonide—Headache—Methotrexate—breast cancer	1.7e-05	0.000203	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Epirubicin—breast cancer	1.68e-05	0.0002	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Doxorubicin—breast cancer	1.67e-05	0.000198	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Epirubicin—breast cancer	1.62e-05	0.000193	CcSEcCtD
Fluocinolone Acetonide—Nausea—Methotrexate—breast cancer	1.61e-05	0.000192	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—breast cancer	1.61e-05	0.000192	CcSEcCtD
Fluocinolone Acetonide—Rash—Epirubicin—breast cancer	1.6e-05	0.000191	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Epirubicin—breast cancer	1.6e-05	0.000191	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCB1—breast cancer	1.6e-05	0.00828	CrCbGaD
Fluocinolone Acetonide—Headache—Epirubicin—breast cancer	1.59e-05	0.00019	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Doxorubicin—breast cancer	1.56e-05	0.000185	CcSEcCtD
Fluocinolone Acetonide—Nausea—Epirubicin—breast cancer	1.51e-05	0.00018	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Doxorubicin—breast cancer	1.5e-05	0.000178	CcSEcCtD
Fluocinolone Acetonide—Rash—Doxorubicin—breast cancer	1.48e-05	0.000177	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—breast cancer	1.48e-05	0.000177	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—breast cancer	1.47e-05	0.000176	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT3B—breast cancer	1.46e-05	0.000288	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HEY2—breast cancer	1.45e-05	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDOA—breast cancer	1.45e-05	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL23A—breast cancer	1.43e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPS6KB2—breast cancer	1.43e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RGS2—breast cancer	1.42e-05	0.000279	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.41e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.41e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.41e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA3—breast cancer	1.4e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL20—breast cancer	1.4e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—breast cancer	1.4e-05	0.000166	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGTR1—breast cancer	1.4e-05	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RARB—breast cancer	1.39e-05	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A2—breast cancer	1.39e-05	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—breast cancer	1.39e-05	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT2—breast cancer	1.39e-05	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.38e-05	0.000272	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.37e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG2—breast cancer	1.37e-05	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CPT1A—breast cancer	1.37e-05	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTR—breast cancer	1.37e-05	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TLE3—breast cancer	1.36e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPAR1—breast cancer	1.36e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HEY1—breast cancer	1.34e-05	0.000265	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HPGDS—breast cancer	1.34e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MED12—breast cancer	1.34e-05	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS7—breast cancer	1.34e-05	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS8—breast cancer	1.34e-05	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—breast cancer	1.33e-05	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HBA1—breast cancer	1.33e-05	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—breast cancer	1.32e-05	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DLL1—breast cancer	1.32e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—breast cancer	1.32e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—breast cancer	1.32e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—breast cancer	1.3e-05	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACHE—breast cancer	1.3e-05	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIST1H2BK—breast cancer	1.29e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIST1H2BC—breast cancer	1.29e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRB7—breast cancer	1.28e-05	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4D—breast cancer	1.28e-05	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.26e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TAB2—breast cancer	1.26e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—breast cancer	1.26e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ITPR1—breast cancer	1.25e-05	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR2—breast cancer	1.25e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MMP3—breast cancer	1.25e-05	0.000245	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP17A1—breast cancer	1.23e-05	0.000242	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	1.23e-05	0.000242	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DKK1—breast cancer	1.22e-05	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO1—breast cancer	1.22e-05	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS1—breast cancer	1.22e-05	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.21e-05	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH4—breast cancer	1.21e-05	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFC—breast cancer	1.21e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.2e-05	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2D6—breast cancer	1.19e-05	0.000235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAG2—breast cancer	1.19e-05	0.000235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAF1—breast cancer	1.19e-05	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	1.19e-05	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—WNT1—breast cancer	1.17e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA2—breast cancer	1.17e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—breast cancer	1.16e-05	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CSF2—breast cancer	1.16e-05	0.000228	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPA1B—breast cancer	1.16e-05	0.000228	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	1.14e-05	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FASN—breast cancer	1.14e-05	0.000224	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—breast cancer	1.13e-05	0.000223	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.12e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—breast cancer	1.12e-05	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH4—breast cancer	1.11e-05	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PGR—breast cancer	1.11e-05	0.000218	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GZMB—breast cancer	1.11e-05	0.000218	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT1—breast cancer	1.09e-05	0.000214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NQO1—breast cancer	1.08e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A1—breast cancer	1.08e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL2—breast cancer	1.07e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR2—breast cancer	1.07e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—breast cancer	1.07e-05	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA2—breast cancer	1.07e-05	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTHLH—breast cancer	1.06e-05	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BMP2—breast cancer	1.06e-05	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.06e-05	0.000208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP3A4—breast cancer	1.05e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EZH2—breast cancer	1.05e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.05e-05	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1B1—breast cancer	1.04e-05	0.000204	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH3—breast cancer	1.03e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PARP1—breast cancer	1.03e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRB—breast cancer	1.03e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PGR—breast cancer	1.02e-05	0.000201	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSP90AA1—breast cancer	1.02e-05	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—THBS1—breast cancer	1.01e-05	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	1.01e-05	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS6—breast cancer	1.01e-05	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA1—breast cancer	9.88e-06	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—breast cancer	9.75e-06	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP19A1—breast cancer	9.73e-06	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STK11—breast cancer	9.73e-06	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FLT1—breast cancer	9.67e-06	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF3—breast cancer	9.63e-06	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SQSTM1—breast cancer	9.63e-06	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAG1—breast cancer	9.51e-06	0.000187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH3—breast cancer	9.47e-06	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PARP1—breast cancer	9.47e-06	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CALCA—breast cancer	9.35e-06	0.000184	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—breast cancer	9.31e-06	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH2—breast cancer	9.24e-06	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPS6—breast cancer	9.24e-06	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF4—breast cancer	9.17e-06	0.000181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.14e-06	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCR4—breast cancer	9.13e-06	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL12—breast cancer	9.13e-06	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—breast cancer	9.07e-06	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COMT—breast cancer	9.05e-06	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—breast cancer	9.01e-06	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA1—breast cancer	8.99e-06	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PAK1—breast cancer	8.96e-06	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—breast cancer	8.88e-06	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ITPR1—breast cancer	8.86e-06	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TCF7L2—breast cancer	8.81e-06	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—breast cancer	8.7e-06	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AR—breast cancer	8.62e-06	0.00017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—breast cancer	8.58e-06	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—breast cancer	8.53e-06	0.000168	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSP90AA1—breast cancer	8.49e-06	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH2—breast cancer	8.49e-06	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMS—breast cancer	8.37e-06	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—breast cancer	8.32e-06	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—breast cancer	8.28e-06	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOR1—breast cancer	8.28e-06	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRL—breast cancer	8.26e-06	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR1—breast cancer	8.26e-06	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STK11—breast cancer	8.14e-06	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADAM10—breast cancer	8.14e-06	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLG—breast cancer	8.05e-06	0.000159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT2—breast cancer	7.96e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—breast cancer	7.93e-06	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF10—breast cancer	7.92e-06	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—breast cancer	7.86e-06	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—breast cancer	7.85e-06	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ERCC2—breast cancer	7.78e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SMAD4—breast cancer	7.76e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—VDR—breast cancer	7.74e-06	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—breast cancer	7.71e-06	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—breast cancer	7.65e-06	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFA—breast cancer	7.64e-06	0.00015	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOR1—breast cancer	7.53e-06	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFBR2—breast cancer	7.53e-06	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITPR1—breast cancer	7.41e-06	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT5A—breast cancer	7.36e-06	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP3—breast cancer	7.36e-06	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB4—breast cancer	7.36e-06	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—H2AFX—breast cancer	7.34e-06	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—breast cancer	7.31e-06	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMAD4—breast cancer	7.13e-06	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—breast cancer	7.09e-06	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ERCC2—breast cancer	7.08e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—breast cancer	7.08e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HES1—breast cancer	6.96e-06	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCOR1—breast cancer	6.92e-06	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—breast cancer	6.85e-06	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF1—breast cancer	6.84e-06	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CSF2—breast cancer	6.84e-06	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAF1—breast cancer	6.83e-06	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRG1—breast cancer	6.79e-06	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—breast cancer	6.75e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—H2AFX—breast cancer	6.74e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F1—breast cancer	6.7e-06	0.000132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—breast cancer	6.67e-06	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—breast cancer	6.55e-06	0.000129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.45e-06	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPP1—breast cancer	6.43e-06	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—breast cancer	6.41e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	6.39e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB3—breast cancer	6.36e-06	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR2—breast cancer	6.35e-06	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—breast cancer	6.15e-06	0.000121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—breast cancer	6.12e-06	0.000121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—breast cancer	6.1e-06	0.00012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR1—breast cancer	5.92e-06	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—breast cancer	5.92e-06	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—breast cancer	5.83e-06	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—breast cancer	5.78e-06	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—breast cancer	5.72e-06	0.000113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—breast cancer	5.69e-06	0.000112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—breast cancer	5.64e-06	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—breast cancer	5.58e-06	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—breast cancer	5.44e-06	0.000107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—breast cancer	5.4e-06	0.000106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FN1—breast cancer	5.37e-06	0.000106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—breast cancer	5.33e-06	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKBIA—breast cancer	5.31e-06	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—breast cancer	5.26e-06	0.000104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—breast cancer	5.14e-06	0.000101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—breast cancer	5.14e-06	0.000101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—breast cancer	5.14e-06	0.000101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—breast cancer	5.1e-06	0.0001	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGF—breast cancer	5.08e-06	0.0001	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—breast cancer	4.92e-06	9.69e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—breast cancer	4.86e-06	9.58e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—breast cancer	4.83e-06	9.51e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—breast cancer	4.71e-06	9.28e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—breast cancer	4.71e-06	9.27e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT2—breast cancer	4.7e-06	9.26e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—breast cancer	4.68e-06	9.22e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—breast cancer	4.67e-06	9.19e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—breast cancer	4.52e-06	8.9e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—breast cancer	4.47e-06	8.8e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—breast cancer	4.42e-06	8.71e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—breast cancer	4.27e-06	8.4e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—breast cancer	4.07e-06	8.01e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—breast cancer	4.06e-06	8e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—breast cancer	4.05e-06	7.97e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAF1—breast cancer	4.03e-06	7.94e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RELA—breast cancer	4.02e-06	7.91e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—breast cancer	3.99e-06	7.86e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—breast cancer	3.94e-06	7.76e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—breast cancer	3.94e-06	7.76e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—breast cancer	3.78e-06	7.45e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—breast cancer	3.76e-06	7.4e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—breast cancer	3.7e-06	7.28e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—breast cancer	3.62e-06	7.13e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—breast cancer	3.62e-06	7.12e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—breast cancer	3.6e-06	7.09e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—breast cancer	3.53e-06	6.94e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—breast cancer	3.52e-06	6.93e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—breast cancer	3.49e-06	6.88e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—breast cancer	3.42e-06	6.74e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—breast cancer	3.41e-06	6.72e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—breast cancer	3.4e-06	6.7e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—breast cancer	3.33e-06	6.56e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—breast cancer	3.32e-06	6.54e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—breast cancer	3.16e-06	6.23e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—breast cancer	3.16e-06	6.21e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—breast cancer	3.08e-06	6.06e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—breast cancer	3.07e-06	6.05e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—breast cancer	3.04e-06	5.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—breast cancer	2.91e-06	5.73e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—breast cancer	2.87e-06	5.65e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—breast cancer	2.83e-06	5.57e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—breast cancer	2.82e-06	5.56e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—breast cancer	2.77e-06	5.45e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—breast cancer	2.61e-06	5.15e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—breast cancer	2.4e-06	4.73e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—breast cancer	2.35e-06	4.62e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—breast cancer	2.32e-06	4.57e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—breast cancer	2.22e-06	4.37e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—breast cancer	2.13e-06	4.2e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—breast cancer	2.13e-06	4.19e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—breast cancer	1.96e-06	3.86e-05	CbGpPWpGaD
